InvestorsHub Logo
Post# of 251888
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 191636

Saturday, 05/23/2015 5:15:05 PM

Saturday, May 23, 2015 5:15:05 PM

Post# of 251888

Why is BXLT’s gene-therapy candidate for hemophilia A about two years behind its gene-therapy candidate for hemophilia B?

I think the large size of human FVIII cDNA (much larger than that of factor IX) was a challenge for delivery by the viral vector (few more problems I can think of but not as challenging), and it took time to overcome this problem.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.